dr. grivas on parp inhibition in metastatic urothelial cancer
Published 5 years ago • 27 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
0:56
dr. grivas on parp inhibition in germline and dna damage repair-mutated mcrpc
-
2:04
dr. grivas on the imvigor211 trial in metastatic urothelial carcinoma
-
1:45
dr. grivas on unmet needs in advanced urothelial cancer
-
1:22
dr. grivas on emerging biomarkers in urothelial cancer
-
1:51
dr. grivas on checkpoint inhibitors in localized bladder cancer
-
1:22
dr. grivas on immunotherapy in platinum-refractory metastatic bladder cancer
-
1:09
dr. grivas on the future of molecular subtyping in urothelial cancer
-
9:10
petros grivas, esmo 2019 - advances in metastatic urothelial cancer
-
1:55
dr. grivas on investigational immunotherapy approaches in localized bladder cancer
-
1:33
dr. grivas on immunotherapy in advanced urothelial cancer
-
1:56
dr. grivas on mechanisms of immune response in bladder cancer
-
1:17
dr. grivas on promising combination therapies in bladder cancer
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
1:12
petros grivas, md, phd, regarding the role of immunotherapy in metastatic bladder cancer
-
1:22
dr. grivas on bladder preservation in localized bladder cancer
-
1:58
dr. george on promise of parp inhibitors in prostate cancer
-
1:38
dr. grivas on the subgroup analyses of the javelin bladder 100 trial in advanced urothelial cancer
-
0:56
dr. grivas on the next steps for immunotherapy in bladder cancer